journal article·2023-07-12Open access

Photonic Lithotripsy: Near-Infrared Laser Activated Nanomaterials for Kidney Stone Comminution

Ian Houlihan, Benjamin Kang, Smita De, Vijay Krishna

Nano Letters· Volume 23· Issue 13

Abstract

Near-infrared activated nanomaterials have been reported for biomedical applications ranging from photothermal tumor destruction to biofilm eradication and energy-gated drug delivery. However, the focus so far has been on soft tissues, and little is known about energy delivery to hard tissues, which have thousand-fold higher mechanical strength. We present photonic lithotripsy with carbon and gold nanomaterials for fragmenting human kidney stones. The efficacy of stone comminution is dependent on the size and photonic properties of the nanomaterials. Surface restructuring and decomposition of calcium oxalate to calcium carbonate support the contribution of photothermal energy to stone failure. Photonic lithotripsy has several advantages over current laser lithotripsy, including low operating power, noncontact laser operation (distances of at least 10 mm), and ability to break all common stones. Our observations can inspire the development of rapid, minimally invasive techniques for kidney stone treatment and extrapolate to other hard tissues such as enamel and bone.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Kidney Stones and Urolithiasis Treatments · Laser-induced spectroscopy and plasma · Intraocular Surgery and Lenses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland Ohio 44195, United States

Urology, Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland Ohio 44195, United States

Urology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Ohio 44106, United States

Biomedical Engineering, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Ohio 44106, United States

Funding

National Institute of Diabetes and Digestive and Kidney Diseases · Lerner Research Institute, Cleveland Clinic · Cleveland Clinic Caregiver Catalyst Award

References (58)

Show source-provided references
1. 10.1177/205141581881382010.1177/2051415818813820 ↗
2. 10.1016/j.eururo.2014.06.03610.1016/j.eururo.2014.06.036 ↗
3. 10.1038/nrdp.2016.810.1038/nrdp.2016.8 ↗
4. 10.1111/bju.1435410.1111/bju.14354 ↗
5. 10.1007/s00330-017-4852-610.1007/s00330-017-4852-6 ↗
6. 10.1016/j.juro.2014.09.00610.1016/j.juro.2014.09.006 ↗
7. 10.1007/s00345-014-1395-110.1007/s00345-014-1395-1 ↗
8. 10.1002/lsm.2305710.1002/lsm.23057 ↗
9. 10.1117/1.JBO.19.12.12800110.1117/1.JBO.19.12.128001 ↗
10. 10.1097/MOU.000000000000081510.1097/MOU.0000000000000815 ↗
11. 10.1089/end.2019.044110.1089/end.2019.0441 ↗
12. 10.1109/10.28494610.1109/10.284946 ↗
13. 10.1364/BOE.9.00455210.1364/BOE.9.004552 ↗
14. 10.1002/(SICI)1096-9101(1999)25:1<22::AID-LSM4>3.0.CO;2-610.1002/(SICI)1096-9101(1999)25:1<22::AID-LSM4>3.0.CO;2-6 ↗
15. 10.1089/08927790175016173710.1089/089277901750161737 ↗
16. Beghuin D. · 1998 · 22010.1117/12.297905 ↗
17. 10.1089/end.1999.13.18110.1089/end.1999.13.181 ↗
18. 10.1002/(SICI)1096-9101(1996)18:3<278::AID-LSM10>3.0.CO;2-210.1002/(SICI)1096-9101(1996)18:3<278::AID-LSM10>3.0.CO;2-2 ↗
19. 10.1016/j.juro.2016.05.09010.1016/j.juro.2016.05.090 ↗
20. Nikdouz A. · Am J Clin Exp Immunol · 2022 · 11 · 1
21. 10.3389/fphar.2018.0140110.3389/fphar.2018.01401 ↗
22. 10.1177/002203451037779410.1177/0022034510377794 ↗
23. 10.1007/s12034-021-02582-410.1007/s12034-021-02582-4 ↗
24. 10.1016/j.pacs.2019.10014410.1016/j.pacs.2019.100144 ↗
25. 10.3390/molecules2209144510.3390/molecules22091445 ↗
26. 10.1038/srep1552710.1038/srep15527 ↗
27. 10.1002/smll.20100084710.1002/smll.201000847 ↗
28. 10.1038/nnano.2010.3510.1038/nnano.2010.35 ↗
29. 10.2217/imt.16.1110.2217/imt.16.11 ↗
30. 10.20900/mo.2019002110.20900/mo.20190021 ↗
31. 10.1016/j.drudis.2012.03.01010.1016/j.drudis.2012.03.010 ↗
32. 10.1016/S1369-7021(11)70059-110.1016/S1369-7021(11)70059-1 ↗
33. 10.3233/CBM-2008-44-50510.3233/CBM-2008-44-505 ↗
34. 10.1007/BF0059160810.1007/BF00591608 ↗
35. 10.1088/1748-605X/ac2b7a10.1088/1748-605X/ac2b7a ↗
36. 10.1016/j.jbiomech.2011.12.00310.1016/j.jbiomech.2011.12.003 ↗
37. 10.1117/1.JBO.19.5.05600410.1117/1.JBO.19.5.056004 ↗
38. 10.1002/jbio.20150019210.1002/jbio.201500192 ↗
39. 10.1021/acsomega.0c0101810.1021/acsomega.0c01018 ↗
40. 10.1021/jp900359210.1021/jp9003592 ↗
41. 10.1007/s10103-006-0390-110.1007/s10103-006-0390-1 ↗
42. 10.1007/s00240-010-0298-x10.1007/s00240-010-0298-x ↗
43. 10.1097/00005392-200008000-0008010.1097/00005392-200008000-00080 ↗
44. 10.1016/j.ajur.2018.08.00610.1016/j.ajur.2018.08.006 ↗
45. 10.1016/j.mayocp.2017.11.01810.1016/j.mayocp.2017.11.018 ↗
46. 10.1155/2018/306836510.1155/2018/3068365 ↗
47. Alatab S. · Iran J Kidney Dis · 2016 · 10 · 51
48. 10.1186/1471-2490-4-1510.1186/1471-2490-4-15 ↗
49. 10.5802/crchim.8910.5802/crchim.89 ↗
50. 10.1007/s10653-018-0237-210.1007/s10653-018-0237-2 ↗
51. 10.1080/00365513.2019.157899510.1080/00365513.2019.1578995 ↗
52. 10.1016/j.jas.2012.06.03610.1016/j.jas.2012.06.036 ↗
53. 10.1016/j.saa.2014.09.04610.1016/j.saa.2014.09.046 ↗
54. 10.1007/s10973-010-0914-610.1007/s10973-010-0914-6 ↗
55. 10.1002/(SICI)1096-9101(1999)25:1<22::AID-LSM4>3.0.CO;2-610.1002/(SICI)1096-9101(1999)25:1<22::AID-LSM4>3.0.CO;2-6 ↗
56. Warty Y. · J Biomed Phys Eng · 2020 · 10 · 273
57. 10.31661/jbpe.v0i0.110410.31661/jbpe.v0i0.1104 ↗
58. 10.1039/C9CP06867H10.1039/C9CP06867H ↗